EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CellSeed's enterprise value is 円6,272.8 Mil.
CellSeed's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円193.7 Mil. Therefore, CellSeed's EV-to-Revenue for today is 32.39.
The historical rank and industry rank for CellSeed's EV-to-Revenue or its related term are showing as below:
TSE:7776'
s EV-to-Revenue Range Over the Past 10 Years
Min: 5.57 Med: 25.49 Max: 240.8
Current: 32.39
During the past 13 years, the highest EV-to-Revenue of CellSeed was 240.80. The lowest was 5.57. And the median was 25.49.
TSE:7776's EV-to-Revenue is ranked worse than 73.46% of 1036
companies
in the Biotechnology industry
Industry Median: 8.17
vs TSE:7776: 32.39
As of today (2024-05-29), CellSeed's stock price is 円255.00.
CellSeed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円6.30. Therefore, CellSeed's PS Ratio for today is 40.46.
CellSeed EV-to-Revenue Historical Data
The historical data trend for CellSeed's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CellSeed's EV-to-Revenue
For the Biotechnology subindustry, CellSeed's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellSeed's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CellSeed's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where CellSeed's EV-to-Revenue falls into.
CellSeed's current Enterprise Value is 円6,272.8 Mil.
CellSeed's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円193.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellSeed's share price for today is 円255.00.
CellSeed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円6.30.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellSeed EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of CellSeed's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7776 has been successfully added to your 